Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin
- PMID: 30395874
- PMCID: PMC6497565
- DOI: 10.1016/j.mce.2018.10.018
Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin
Abstract
The pathophysiology of anorexia nervosa (AN) and bulimia nervosa (BN) are still poorly understood, but psychobiological models have proposed a key role for disturbances in the neuroendocrines that signal hunger and satiety and maintain energy homeostasis. Mounting evidence suggests that many neuroendocrines involved in the regulation of homeostasis and body weight also play integral roles in food reward valuation and learning via their interactions with the mesolimbic dopamine system. Neuroimaging data have associated altered brain reward responses in this system with the dietary restriction and binge eating and purging characteristic of AN and BN. Thus, neuroendocrine dysfunction may contribute to or perpetuate eating disorder symptoms via effects on reward circuitry. This narrative review focuses on reward-related neuroendocrines that are altered in eating disorder populations, including peptide YY, insulin, stress and gonadal hormones, and orexins. We provide an overview of the animal and human literature implicating these neuroendocrines in dopaminergic reward processes and discuss their potential relevance to eating disorder symptomatology and treatment.
Keywords: Anorexia nervosa; Bulimia nervosa; Dopamine; Neuroendocrinology; Reward.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Neuroendocrinology and brain imaging of reward in eating disorders: A possible key to the treatment of anorexia nervosa and bulimia nervosa.Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jan 3;80(Pt B):132-142. doi: 10.1016/j.pnpbp.2017.02.020. Epub 2017 Mar 1. Prog Neuropsychopharmacol Biol Psychiatry. 2018. PMID: 28259721 Review.
-
Neuroendocrine aspects of anorexia nervosa and bulimia nervosa.Neuro Endocrinol Lett. 2018 Sep;39(3):172-178. Neuro Endocrinol Lett. 2018. PMID: 30431742 Review.
-
Test of a biobehavioral model linking weight suppression to binge-eating severity via leptin and glucagon-like peptide 1 in bulimia nervosa and related syndromes in women.Psychol Med. 2025 Jun 27;55:e177. doi: 10.1017/S0033291725100871. Psychol Med. 2025. PMID: 40576074 Free PMC article.
-
Dysregulation of brain reward systems in eating disorders: neurochemical information from animal models of binge eating, bulimia nervosa, and anorexia nervosa.Neuropharmacology. 2012 Jul;63(1):87-96. doi: 10.1016/j.neuropharm.2011.11.010. Epub 2011 Nov 27. Neuropharmacology. 2012. PMID: 22138162 Free PMC article. Review.
-
Central and peripheral peptides regulating eating behaviour and energy homeostasis in anorexia nervosa and bulimia nervosa: a literature review.Eur Eat Disord Rev. 2014 Sep;22(5):307-20. doi: 10.1002/erv.2303. Epub 2014 Jun 18. Eur Eat Disord Rev. 2014. PMID: 24942507 Review.
Cited by
-
Validity and utility of Hierarchical Taxonomy of Psychopathology (HiTOP): III. Emotional dysfunction superspectrum.World Psychiatry. 2022 Feb;21(1):26-54. doi: 10.1002/wps.20943. World Psychiatry. 2022. PMID: 35015357 Free PMC article.
-
Ketamine and Zinc: Treatment of Anorexia Nervosa Via Dual NMDA Receptor Modulation.CNS Drugs. 2023 Feb;37(2):159-180. doi: 10.1007/s40263-022-00984-4. Epub 2023 Jan 22. CNS Drugs. 2023. PMID: 36681939 Free PMC article. Review.
-
A Transdiagnostic Perspective on Social Anhedonia.Front Psychiatry. 2019 Apr 24;10:216. doi: 10.3389/fpsyt.2019.00216. eCollection 2019. Front Psychiatry. 2019. PMID: 31105596 Free PMC article. Review.
-
Anandamide and 2-arachidonoylglycerol baseline plasma concentrations and their clinical correlate in gambling disorder.Eur Psychiatry. 2023 Nov 8;66(1):e97. doi: 10.1192/j.eurpsy.2023.2460. Eur Psychiatry. 2023. PMID: 37937379 Free PMC article.
-
Peptide YY3-36 concentration in acute- and long-term recovered anorexia nervosa.Eur J Nutr. 2020 Dec;59(8):3791-3799. doi: 10.1007/s00394-020-02210-7. Epub 2020 Mar 12. Eur J Nutr. 2020. PMID: 32166384 Free PMC article.
References
-
- Abbott C, Small C, Kennedy A, Neary N, Sajedi A, Ghatei M, et al. (2005). Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3–36) on food intake. Brain Res 1043(1–2): 139–144. - PubMed
-
- Adam T, Epel E (2007). Stress, eating and the reward system. Phys Behav 91: 449 – 458. - PubMed
-
- Adewale AS, Macarthur H, Westfall TC (2007). Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: Mediation by Y2 receptors. Neuropharmacology 52(6): 1396–1402. - PubMed
-
- Adrian T, Ferri G, Bacarese-Hamilton A, Fuessl H, Polak J, Bloom S (1985). Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 89(5): 1070–1077. - PubMed
-
- Air E, Benoit S, Blake Smith K, Clegg D, Woods S (2002a). Acute third ventricular administration of insulin decreases food intake in two paradigms. Pharmacol Biochem Behav 72(1–2): 423–429. - PubMed